Methylphenidate XR (Aptensio)
APTENSIO XR
Pronunciation: meth-il-FEN-i-dayt
“App tension”
Wide eyes → stimulant
Scantron → methylphenidate product (“Math final date”)
What it isExtended-release dopamine and norepinephrine reuptake inhibitor (APTENSIO XR, 2015); ADHD.
Why this oneIts sprinklable capsule uses 40% IR / 60% DR beads and provides 8-12 h (Carlat Table 1) of action.
What limits itAbuse and dependence remain stimulant risks. Appetite loss, insomnia, and blood-pressure elevation often limit treatment.
FDA-approved for
- ADHD (2015)
⚠ BOXED WARNING
- Abuse, misuse and addiction
Classes and tags
Clinical profile
Legacy pregnancy categoryC
Defining liabilityHypertension, appetite/weight effects, misuse and stimulant-induced psychosis or arrhythmia.
Open Methylphenidate XR (Aptensio) in the interactive console ↗
Memory aids: interaction avatars
Open Methylphenidate XR (Aptensio) in the interactive console ↗
Self-check
- What is APTENSIO XR’s bead ratio?
40% IR / 60% DR. - What action duration is listed for APTENSIO XR?
8–12 h (Carlat Table 1).